Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications

Serum copper concentration and ceruloplasmin activity were measured in patients with clinically established rheumatoid arthritis (R.A.) during the active phase, in patients with degenerative joint disease (D.J.D.) and in normal subjects. Copper and ceruloplasmin serum levels are significantly increa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological research communications 1983-10, Vol.15 (9), p.859-867
Hauptverfasser: Conforti, A., Franco, L., Menegale, G., Milanino, R., Piemonte, G., Velo, G.P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 867
container_issue 9
container_start_page 859
container_title Pharmacological research communications
container_volume 15
creator Conforti, A.
Franco, L.
Menegale, G.
Milanino, R.
Piemonte, G.
Velo, G.P.
description Serum copper concentration and ceruloplasmin activity were measured in patients with clinically established rheumatoid arthritis (R.A.) during the active phase, in patients with degenerative joint disease (D.J.D.) and in normal subjects. Copper and ceruloplasmin serum levels are significantly increased (P < 0.01) in the arthritic group, but not in the degenerative joint disease group. Copper and ceruloplasmin levels are high significantly correlated in all the groups. This parallel enhancement of serum copper and ceruloplasmin in R.A. is commented in view of a possible protective role of endogenous copper and/or ceruloplasmin in inflammation.
doi_str_mv 10.1016/S0031-6989(83)80093-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80780699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0031698983800939</els_id><sourcerecordid>80780699</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-ad80d66015daf6c444de5b45793ca8005472826548ffb66243a83c56a98fa6ba3</originalsourceid><addsrcrecordid>eNqFkE2PFCEQhonRrOPqT9iEgzF6aIWmm4aTMRu_kk08rJ5JDVTvsKGbFuhJPPvHZT4yV08UvE8V8BByw9l7zrj8cM-Y4I3USr9V4p1iTItGPyEbrgbdtFrIp2RzQZ6TFzk_1m0rObsiV1J2Q9-qDfl7j2mdqI3LgonC7KitByEuAfLkZxpwjyHTWqUdrhOU6B2FVHbJF5-PDQ4fcMYExe-RPkY_F-p8Rsh4jMsOfaLLDtIENob44C0E6qcl1KL4OOeX5NkIIeOr83pNfn35_PP2W3P34-v32093jRVKlwacYk5KxnsHo7Rd1znst10_aGGh_r_vhla1su_UOG6lbDsBStheglYjyC2Ia_LmNHdJ8feKuZjJZ4shwIxxzUaxQTGpdQX7E2hTzDnhaJbkJ0h_DGfmIN8c5ZuDWaOEOco3h76b8wXrdkJ36Trbrvnrcw65ShgTzNbnC6Z7xrnkFft4wqp53HtMJluPs0XnE9piXPT_ecg_7NGj9g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80780699</pqid></control><display><type>article</type><title>Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Conforti, A. ; Franco, L. ; Menegale, G. ; Milanino, R. ; Piemonte, G. ; Velo, G.P.</creator><creatorcontrib>Conforti, A. ; Franco, L. ; Menegale, G. ; Milanino, R. ; Piemonte, G. ; Velo, G.P.</creatorcontrib><description>Serum copper concentration and ceruloplasmin activity were measured in patients with clinically established rheumatoid arthritis (R.A.) during the active phase, in patients with degenerative joint disease (D.J.D.) and in normal subjects. Copper and ceruloplasmin serum levels are significantly increased (P &lt; 0.01) in the arthritic group, but not in the degenerative joint disease group. Copper and ceruloplasmin levels are high significantly correlated in all the groups. This parallel enhancement of serum copper and ceruloplasmin in R.A. is commented in view of a possible protective role of endogenous copper and/or ceruloplasmin in inflammation.</description><identifier>ISSN: 0031-6989</identifier><identifier>EISSN: 1879-2936</identifier><identifier>DOI: 10.1016/S0031-6989(83)80093-9</identifier><identifier>PMID: 6647528</identifier><language>eng</language><publisher>Orlando, FL: Elsevier B.V</publisher><subject>Arthritis, Rheumatoid - blood ; Arthritis, Rheumatoid - drug therapy ; Biological and medical sciences ; Ceruloplasmin - metabolism ; Copper - blood ; Diseases of the osteoarticular system ; Female ; Humans ; Inflammatory joint diseases ; Male ; Medical sciences ; Osteoarthritis - blood ; Osteoarthritis - drug therapy</subject><ispartof>Pharmacological research communications, 1983-10, Vol.15 (9), p.859-867</ispartof><rights>1983 The Italian Pharmacological Society</rights><rights>1984 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-ad80d66015daf6c444de5b45793ca8005472826548ffb66243a83c56a98fa6ba3</citedby><cites>FETCH-LOGICAL-c389t-ad80d66015daf6c444de5b45793ca8005472826548ffb66243a83c56a98fa6ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9501161$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6647528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Conforti, A.</creatorcontrib><creatorcontrib>Franco, L.</creatorcontrib><creatorcontrib>Menegale, G.</creatorcontrib><creatorcontrib>Milanino, R.</creatorcontrib><creatorcontrib>Piemonte, G.</creatorcontrib><creatorcontrib>Velo, G.P.</creatorcontrib><title>Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications</title><title>Pharmacological research communications</title><addtitle>Pharmacol Res Commun</addtitle><description>Serum copper concentration and ceruloplasmin activity were measured in patients with clinically established rheumatoid arthritis (R.A.) during the active phase, in patients with degenerative joint disease (D.J.D.) and in normal subjects. Copper and ceruloplasmin serum levels are significantly increased (P &lt; 0.01) in the arthritic group, but not in the degenerative joint disease group. Copper and ceruloplasmin levels are high significantly correlated in all the groups. This parallel enhancement of serum copper and ceruloplasmin in R.A. is commented in view of a possible protective role of endogenous copper and/or ceruloplasmin in inflammation.</description><subject>Arthritis, Rheumatoid - blood</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Ceruloplasmin - metabolism</subject><subject>Copper - blood</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Osteoarthritis - blood</subject><subject>Osteoarthritis - drug therapy</subject><issn>0031-6989</issn><issn>1879-2936</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE2PFCEQhonRrOPqT9iEgzF6aIWmm4aTMRu_kk08rJ5JDVTvsKGbFuhJPPvHZT4yV08UvE8V8BByw9l7zrj8cM-Y4I3USr9V4p1iTItGPyEbrgbdtFrIp2RzQZ6TFzk_1m0rObsiV1J2Q9-qDfl7j2mdqI3LgonC7KitByEuAfLkZxpwjyHTWqUdrhOU6B2FVHbJF5-PDQ4fcMYExe-RPkY_F-p8Rsh4jMsOfaLLDtIENob44C0E6qcl1KL4OOeX5NkIIeOr83pNfn35_PP2W3P34-v32093jRVKlwacYk5KxnsHo7Rd1znst10_aGGh_r_vhla1su_UOG6lbDsBStheglYjyC2Ia_LmNHdJ8feKuZjJZ4shwIxxzUaxQTGpdQX7E2hTzDnhaJbkJ0h_DGfmIN8c5ZuDWaOEOco3h76b8wXrdkJ36Trbrvnrcw65ShgTzNbnC6Z7xrnkFft4wqp53HtMJluPs0XnE9piXPT_ecg_7NGj9g</recordid><startdate>198310</startdate><enddate>198310</enddate><creator>Conforti, A.</creator><creator>Franco, L.</creator><creator>Menegale, G.</creator><creator>Milanino, R.</creator><creator>Piemonte, G.</creator><creator>Velo, G.P.</creator><general>Elsevier B.V</general><general>Academic Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198310</creationdate><title>Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications</title><author>Conforti, A. ; Franco, L. ; Menegale, G. ; Milanino, R. ; Piemonte, G. ; Velo, G.P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-ad80d66015daf6c444de5b45793ca8005472826548ffb66243a83c56a98fa6ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Arthritis, Rheumatoid - blood</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Ceruloplasmin - metabolism</topic><topic>Copper - blood</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Osteoarthritis - blood</topic><topic>Osteoarthritis - drug therapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Conforti, A.</creatorcontrib><creatorcontrib>Franco, L.</creatorcontrib><creatorcontrib>Menegale, G.</creatorcontrib><creatorcontrib>Milanino, R.</creatorcontrib><creatorcontrib>Piemonte, G.</creatorcontrib><creatorcontrib>Velo, G.P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Conforti, A.</au><au>Franco, L.</au><au>Menegale, G.</au><au>Milanino, R.</au><au>Piemonte, G.</au><au>Velo, G.P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications</atitle><jtitle>Pharmacological research communications</jtitle><addtitle>Pharmacol Res Commun</addtitle><date>1983-10</date><risdate>1983</risdate><volume>15</volume><issue>9</issue><spage>859</spage><epage>867</epage><pages>859-867</pages><issn>0031-6989</issn><eissn>1879-2936</eissn><abstract>Serum copper concentration and ceruloplasmin activity were measured in patients with clinically established rheumatoid arthritis (R.A.) during the active phase, in patients with degenerative joint disease (D.J.D.) and in normal subjects. Copper and ceruloplasmin serum levels are significantly increased (P &lt; 0.01) in the arthritic group, but not in the degenerative joint disease group. Copper and ceruloplasmin levels are high significantly correlated in all the groups. This parallel enhancement of serum copper and ceruloplasmin in R.A. is commented in view of a possible protective role of endogenous copper and/or ceruloplasmin in inflammation.</abstract><cop>Orlando, FL</cop><cop>London</cop><pub>Elsevier B.V</pub><pmid>6647528</pmid><doi>10.1016/S0031-6989(83)80093-9</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6989
ispartof Pharmacological research communications, 1983-10, Vol.15 (9), p.859-867
issn 0031-6989
1879-2936
language eng
recordid cdi_proquest_miscellaneous_80780699
source MEDLINE; Alma/SFX Local Collection
subjects Arthritis, Rheumatoid - blood
Arthritis, Rheumatoid - drug therapy
Biological and medical sciences
Ceruloplasmin - metabolism
Copper - blood
Diseases of the osteoarticular system
Female
Humans
Inflammatory joint diseases
Male
Medical sciences
Osteoarthritis - blood
Osteoarthritis - drug therapy
title Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T14%3A46%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20copper%20and%20ceruloplasmin%20levels%20in%20rheumatoid%20arthritis%20and%20degenerative%20joint%20disease%20and%20their%20pharmacological%20implications&rft.jtitle=Pharmacological%20research%20communications&rft.au=Conforti,%20A.&rft.date=1983-10&rft.volume=15&rft.issue=9&rft.spage=859&rft.epage=867&rft.pages=859-867&rft.issn=0031-6989&rft.eissn=1879-2936&rft_id=info:doi/10.1016/S0031-6989(83)80093-9&rft_dat=%3Cproquest_cross%3E80780699%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80780699&rft_id=info:pmid/6647528&rft_els_id=S0031698983800939&rfr_iscdi=true